Sato K, Kameyama M, Ishiwata K, Hatazawa J, Katakura R, Yoshimoto T
Division of Neurosurgery, Tohoku University School of Medicine, Sendai, Japan.
Eur J Nucl Med. 1992;19(6):426-30. doi: 10.1007/BF00177369.
In order to evaluate the methionine uptake of a glioma with positron emission tomography (PET), the kinetics of carbon-11 methionine was investigated in 11 patients by measuring the free 11C-methionine in plasma as an input function following intravenous administration. When the mean clearance curve of free 11C-methionine in plasma instead of individual 11C-methionine clearance curves was used, mean differences in uptake rate and distribution volume were 4.0% and 4.6% respectively. By applying the mean clearance curve of free 11C-methionine in 18 glioma patients, significant differences in 11C-methionine uptake rate and distribution volume were found according to pathological grading. For the accurate evaluation of the metabolism of 11C-methionine, it is therefore preferable that the actual level of free 11C-methionine in the plasma be measured, especially for the follow-up of individual cases. The study also demonstrated that the mean clearance curve of 11C-methionine in plasma might be employed as an input curve for calculating the uptake rate and distribution volume with small errors.
为了通过正电子发射断层扫描(PET)评估神经胶质瘤对蛋氨酸的摄取情况,对11例患者静脉注射后,通过测量血浆中游离的碳-11蛋氨酸作为输入函数,研究了碳-11蛋氨酸的动力学。当使用血浆中游离碳-11蛋氨酸的平均清除曲线而非个体碳-11蛋氨酸清除曲线时,摄取率和分布容积的平均差异分别为4.0%和4.6%。通过应用18例神经胶质瘤患者血浆中游离碳-11蛋氨酸的平均清除曲线,发现根据病理分级,碳-11蛋氨酸摄取率和分布容积存在显著差异。因此,为了准确评估碳-11蛋氨酸的代谢情况,尤其是对于个体病例的随访,最好测量血浆中游离碳-11蛋氨酸的实际水平。该研究还表明,血浆中碳-11蛋氨酸的平均清除曲线可用作输入曲线,以计算摄取率和分布容积,误差较小。